subcutaneous adipose tissue; skin wound tissues
-
other disease animal model
autophagy (promotes); apoptosis (inhibits); ceRNA regulation (promotes); angiogenesis (promotes); inflammation (inhibits); other pathway/process (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; RT-qPCR; RNA-seq; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; Annexin V/PI Flow Cytometry; TUNEL; Western Blot; In Vivo Animal Model; H&E Staining; ELISA; IF (Immunofluorescence); Bioinformatics Analysis
Potential therapeutic target for MSC-based diabetic wound healing.
circARHGAP12 is downregulated in human MSCs under high-glucose conditions relevant to diabetic wounds. It functions as a cytoplasmic ceRNA that sponges miR-301b-3p, increases ATG16L1 and ULK2 expression, enhances autophagy, reduces MSC apoptosis, and improves MSC-mediated repair of diabetic wounds in vivo.
0.8131
CircARHGAP12 Triggers Mesenchymal Stromal Cell Autophagy to Facilitate its Effect on Repairing Diabetic Wounds by Sponging miR-301b-3p/ATG16L1 and miR-301b-3p/ULK2.
biological research